These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 22086260)

  • 1. Time to rethink: an evidence-based response from pelvic surgeons to the FDA Safety Communication: "UPDATE on Serious Complications Associated with Transvaginal Placement of Surgical Mesh for Pelvic Organ Prolapse".
    Murphy M; Holzberg A; van Raalte H; Kohli N; Goldman HB; Lucente V;
    Int Urogynecol J; 2012 Jan; 23(1):5-9. PubMed ID: 22086260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transvaginal placement of surgical mesh for pelvic organ prolapse: more FDA concerns--positive reactions are possible.
    Haylen BT; Sand PK; Swift SE; Maher C; Moran PA; Freeman RM
    Int Urogynecol J; 2012 Jan; 23(1):11-3. PubMed ID: 22086259
    [No Abstract]   [Full Text] [Related]  

  • 3. Trends in internet search activity, media coverage, and patient-centered health information after the FDA safety communications on surgical mesh for pelvic organ prolapse.
    Stone BV; Forde JC; Levit VB; Lee RK; Te AE; Chughtai B
    Int Urogynecol J; 2016 Nov; 27(11):1761-1766. PubMed ID: 27209310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaginal placement of synthetic mesh for pelvic organ prolapse.
    Committee on Gynecologic Practice
    Female Pelvic Med Reconstr Surg; 2012; 18(1):5-9. PubMed ID: 22453257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient safety communication from the Food and Drug Administration regarding transvaginal mesh for pelvic organ prolapse surgery.
    Stanford E; Moen M
    J Minim Invasive Gynecol; 2011; 18(6):689-91. PubMed ID: 22024255
    [No Abstract]   [Full Text] [Related]  

  • 6. Vaginal Mesh in Pelvic Reconstructive Surgery: Controversies, Current Use, and Complications.
    Unger CA; Barber MD
    Clin Obstet Gynecol; 2015 Dec; 58(4):740-53. PubMed ID: 26512439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Food and Drug Administration Safety Communication on the Use of Transvaginal Mesh in Pelvic Organ Prolapse Repair Surgery: The Impact of Social Determinants of Health.
    Mao J; Chughtai B; Ibrahim S; Sedrakyan A
    Female Pelvic Med Reconstr Surg; 2021 Jan; 27(1):e133-e138. PubMed ID: 32453208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anterior pelvic organ prolapse repair using synthetic mesh.
    Patel BN; Lucioni A; Kobashi KC
    Curr Urol Rep; 2012 Jun; 13(3):211-5. PubMed ID: 22588645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Committee Opinion no. 513: vaginal placement of synthetic mesh for pelvic organ prolapse.
    Obstet Gynecol; 2011 Dec; 118(6):1459-1464. PubMed ID: 22105294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complications of vaginal mesh surgery.
    Chermansky CJ; Winters JC
    Curr Opin Urol; 2012 Jul; 22(4):287-91. PubMed ID: 22617058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transvaginal mesh: a historical review and update of the current state of affairs in the United States.
    Iyer S; Botros SM
    Int Urogynecol J; 2017 Apr; 28(4):527-535. PubMed ID: 27549225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Where to for pelvic organ prolapse treatment after the FDA pronouncements? A systematic review of the recent literature.
    van Geelen JM; Dwyer PL
    Int Urogynecol J; 2013 May; 24(5):707-18. PubMed ID: 23306770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transvaginal mesh in the media following the 2011 US food and drug administration public health notification update.
    Koo K; Gormley EA
    Neurourol Urodyn; 2017 Feb; 36(2):329-332. PubMed ID: 26575470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inaccuracies in News Media Reporting About the 2019 US Food and Drug Administration Ban on Transvaginal Mesh for Pelvic Organ Prolapse Repair.
    Ray S; Clifton MM; Koo K
    Urology; 2021 Apr; 150():194-200. PubMed ID: 32439554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transvaginal mesh kits--how "serious" are the complications and are they reversible?
    Lee D; Dillon B; Lemack G; Gomelsky A; Zimmern P
    Urology; 2013 Jan; 81(1):43-8. PubMed ID: 23200966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rate of Pelvic Organ Prolapse Surgery Among Privately Insured Women in the United States, 2010-2013.
    Sammarco AG; Swenson CW; Kamdar NS; Kobernik EK; DeLancey JOL; Nallamothu B; Morgan DM
    Obstet Gynecol; 2018 Mar; 131(3):484-492. PubMed ID: 29420405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pelvic mesh complications in women before and after the 2011 FDA public health notification.
    Rice NT; Hu Y; Slaughter JC; Ward RM
    Female Pelvic Med Reconstr Surg; 2013; 19(6):333-8. PubMed ID: 24165446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. U.S. Food and Drug Administration Statements About Transvaginal Mesh and Changes in Apical Prolapse Surgery.
    Winkelman WD; Modest AM; Richardson ML
    Obstet Gynecol; 2019 Oct; 134(4):745-752. PubMed ID: 31503162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Concomitant Stress Incontinence Surgery at Time of Pelvic Organ Prolapse Surgery Since Release of the 2011 Notification on Serious Complications Associated with Transvaginal Mesh.
    Drain A; Khan A; Ohmann EL; Brucker BM; Smilen S; Rosenblum N; Nitti VW
    J Urol; 2017 Apr; 197(4):1092-1098. PubMed ID: 27866958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New considerations in the use of vaginal mesh for prolapse repair.
    Rardin CR; Washington BB
    J Minim Invasive Gynecol; 2009; 16(3):360-4. PubMed ID: 19423069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.